Logo Carlo Sessa : GPS Coordinates 45.529507 - 9.226839

Carlo Sessa

Seoul-based Cenyx operates an advanced cosmetic lab developing nanomedicine solutions through proprietary CX synthesis technology for inflammatory diseases treatment.

Presentation of Carlo Sessa

Located in Seoul, South Korea, cosmetic lab Cenyx advances nanomedicine through its proprietary CX synthesis platform. Since 2016, the lab specializes in:

  • Nanozyme development for inflammatory diseases
  • Biotech agents for nervous system treatments
  • Clinical research and drug pipeline programs
  • Enzymatic reaction optimization

With orphan drug designation granted in 2025, Cenyx continues expanding its therapeutic applications in the growing South Korean biotech sector.

Carlo Sessa newsfeed

  • Cenyx has not yet been verified. The newsfeed is disabled.

Detailed presentation of Carlo Sessa

Innovative biotech solutions at Cenyx

Founded in 2016, Cenyx operates from Seoul, South Korea, as a pioneering biotechnology company. Starting as a cosmetic lab, the company has evolved into a leader in nanomedicine development.

Advanced technological capabilities

At the core of Cenyx’s operations is their proprietary CX synthesis platform, which enables the development of specialized nanozymes. The company has created innovative nano-biotech agents with unique capabilities in managing oxidative stress through the removal of multiple radical compounds.

Research and development focus

  • Development of therapeutic nanozymes
  • Management of inflammatory conditions
  • Nervous system disease treatments
  • Advanced enzymatic reaction research

Strategic location in South Korea’s biotech hub

Based in Seoul’s biotechnology district, Cenyx benefits from South Korea’s advanced pharmaceutical research infrastructure. This location positions the company within a network of leading research institutions and medical facilities.

Current developments and achievements

The company maintains four active pipeline programs targeting both acute and chronic inflammatory conditions. In early 2025, Cenyx received orphan designation status, marking a significant milestone in their drug development journey.

Areas of specialization

  • Nanozyme technology implementation
  • Therapeutic applications development
  • Clinical trials management
  • Biotech agent optimization

Future directions

Cenyx continues to expand its drug pipeline while strengthening its position in the South Korean biotech sector. The company’s work in nervous system disease treatment represents a growing focus area within their research portfolio.

Services provided by Carlo Sessa

Below you will find the services provided by Cenyx. Like each cosmetic lab on the platform, the services are manually registered by the providing company.

  • Cenyx has no service catalogue on cosmetic-labs.com.

Gallery and medias

  • Cenyx has not yet posted any media. There is no gallery yet.

Locate Carlo Sessa

Contact Carlo Sessa

  • Cenyx has not yet been verified. Messaging is disabled.

Carlo Sessa opening hours

Closed all day

  • Monday

    Closed all day
  • Tuesday

    Closed all day
  • Wednesday

    Closed all day
  • Thursday

    Closed all day
  • Friday

    Closed all day
  • Saturday

    Closed all day
  • Sunday

    Closed all day
  • Local time

    September 19, 2025 7:24 pm

Frequent questions

Cenyx focuses on the following areas:

  • Nanozyme Technology
    • CX synthesis platform
    • Nano-biotech agents
    • Enzymatic reaction catalysts
  • Disease Treatment
    • Inflammatory disease therapies
    • Nervous system treatments
    • Drug development programs
  • Research Programs
    • Clinical trials
    • Pharmaceutical studies
    • Drug pipeline development

The company operates under pharmaceutical industry regulations and standards.

Cenyx focuses on the following areas:

  • Nanozyme Technology
    • CX synthesis platform
    • Nano-biotech agents
    • Enzymatic reaction catalysts
  • Disease Treatment
    • Inflammatory disease therapies
    • Nervous system treatments
    • Drug development programs
  • Research Programs
    • Clinical trials
    • Pharmaceutical studies
    • Drug pipeline development

The company operates under pharmaceutical industry regulations and standards.

Cenyx focuses on the following areas:

  • Nanozyme Technology
    • CX synthesis platform
    • Nano-biotech agents
    • Enzymatic reaction catalysts
  • Disease Treatment
    • Inflammatory disease therapies
    • Nervous system treatments
    • Drug development programs
  • Research Programs
    • Clinical trials
    • Pharmaceutical studies
    • Drug pipeline development

The company operates under pharmaceutical industry regulations and standards.

Explore

Find a cosmetic lab in Italy

Click below to see the profile of a cosmetic lab similar to Carlo Sessa in Italy.

Usp Indicator Solutions operates cosmetic labs in Klagenfurt, Austria, providing scientific product demonstrations and efficacy testing for consumer goods brands.
Bioalkemia, a cosmetic lab in Doral, Florida, manufactures over 150 specialized ingredients including actives, vitamins and natural extracts for skin care products.
The International Federation of Societies of Cosmetic Chemists, based in Zug, Switzerland, connects 51 societies across 81 countries for cosmetic science advancement.
Kahl operates a state-of-the-art cosmetic lab in Trittau, Germany, specializing in natural wax manufacturing and sustainable cosmetic ingredients for global markets.
Kawaken cosmetic lab in Singapore manufactures certified organic ingredients and surfactants, serving 30+ international brands across Asia-Pacific since 2013.
Laboratoire Watchfrog in Évry-Courcouronnes provides endocrine disruptor testing services using patented methodologies that comply with European regulations.